Page 11 of 14
Organic & Biomolecular Chemistry
2,3-Dimethyl-1-(pent-4-en-1-yl)indole 4t
By the same general method, butanone (64 µL, 0.716 mmol, 1.05 eq.), phenylhydrazineDOI: 10.1039/D0OB02185G
hydrochloride (99 mg, 0.682 mmol, 1 eq.) and 5-bromo-1-pentene (85 µL, 0.716 mmol, 1.05 eq.)
gave 2,3-dimethyl-1-(pent-4-en-1-yl)indole 4t (135 mg, 92%) as a red oil, Rf 0.2 (hexane); νmax = 3052,
2915, 2858, 1640, 1469, 1415, 1354, 1333, 1242, 1181, 1013, 992, 910 and 733 cm–1; δH(400 MHz,
CDCl3) 7.39 (1 H, d, J 7.1, 4-H), 7.13 (1 H, d, J 7.1, 7-H), 7.04 (1 H, t, J 7.1, 6-H), 6.97 (1 H, t, J 7.1, 5-H),
5.72 (1 H, ddt, J 16.3, 10.1, 7.0, 4’-H), 4.96 (1 H, dd, J 16.3, 1.6, 5’-H), 4.92 (1 H, dd, J 10.1, 1.6, 5’-H),
3.92 (2 H, t, J 7.0, 1’-CH2), 2.23 (3 H, s, 2-CH3), 2.16 (3 H, s, 3-CH3), 2.00 (2 H, q, J 7.0, 3’-CH2) and 1.70
(2 H, pentet, J 7.0, 2’-CH2); δC(100 MHz, CDCl3) 137.7 (4’), 135.9 (7a), 132.2 (2), 128.8 (3a), 120.5 (6),
118.8 (5), 118.1 (4), 115.5 (5’), 108.7 (7), 106.5 (3), 42.7 (1’), 31.3 (3’), 29.4 (2’), 10.3 (2-CH3) and 9.0
(3-CH3); HRMS-ES (m/z): Found: 214.1590 (MH+, C15H20N requires: 214.1595).
1-(Hex-5-yn-1-yl)-2,3-dimethylindole 4u
By the same general method, butanone (64 µL, 0.716 mmol, 1.05 eq.), phenylhydrazine
hydrochloride (99 mg, 0.682 mmol, 1 eq.) and 6-iodo-1-hexyne (94 µL, 0.716 mmol, 1.05 eq.) gave 1-
(hex-5-yn-1-yl)-2,3-dimethylindole 4u (134 mg, 87%) as a purple oil, Rf 0.2 (2% ethyl acetate in
hexane); νmax = 3056, 2917, 2860, 2587, 1469, 1357, 1230, 1242, 1217, 1013 and 734 cm–1; δH(400
MHz, CDCl3) 7.39 (1 H, d, J 7.5, 4-H), 7.14 (1 H, d, J 7.5, 7-H), 7.04 (1 H, t, J 7.5, 6-H), 6.98 (1 H, t, J 7.5,
5-H), 3.95 (2 H, t, J 7.3, 1’-CH2), 2.24 (3 H, s, 2-CH3), 2.16 (3 H, s, 3-CH3), 2.10 (2 H, dt, J 7.0, 2.6, 4’-
CH2), 1.86 (1 H, t, J 2.6, 6’-H), 1.79–1.70 (2 H, m, 2’-CH2) and 1.50–1.41 (2 H, m, 3’-CH2); δC(100 MHz,
CDCl3) 135.9 (7a), 132.1 (2), 128.6 (3a), 120.5 (6), 118.6 (5), 118.0 (4), 108.7 (7), 106.6 (3), 83.9 (5’),
69.0 (6’), 42.8 (1’), 29.5 (2’), 25.9 (3’), 18.3 (4’), 10.3 (2-CH3) and 9.0 (3-CH3); HRMS-ES (m/z): Found:
226.1583 (MH+, C16H20N requires: 226.1595).
2,3-Dimethyl-1-(1-phenylethyl)indole 4v
By the same general method, butanone (64 µL, 0.716 mmol, 1.05 eq.), phenylhydrazine
hydrochloride (99 mg, 0.682 mmol, 1 eq.) and (1-bromoethyl)benzene (98 µL, 0.716 mmol, 1.05 eq.)
gave 2,3-dimethyl-1-(1-phenylethyl)indole 4v (98 mg, 63%) as an amorphous yellow solid,
Rf 0.1 (hexane); νmax = 3016, 2970, 2946, 1441, 1365, 1229, 1217, 1091 and 747 cm–1; δH(400 MHz,
CDCl3) 7.41 (1 H, d, J 7.7, 4-H), 7.23–7.11 (3 H, m, Bn 3-, 4- and 5-H), 7.08 (2 H, d, J 7.8, Bn 2- and 6-
H), 6.96–6.85 (3 H, m, 5-, 6- and 7-H), 5.65 (1 H, q, J 7.1, CHCH3), 2.18 (6 H, s, 2- and 3-CH3) and 1.82
(3 H, d, J 7.1, CHCH3); δC(100 MHz, CDCl3) 140.8 (Bn1), 134.1 (7a), 131.3 (2), 128.1 (3a), 127.4
(Bn3,5), 125.9 (Bn4), 125.2 (Bn2,6), 119.2 (6), 117.4 (5), 116.9 (4), 109.5 (7), 106.2 (3), 51.2 (CHCH3),
17.6 (CHCH3), 10.1 (2-CH3) and 7.9 (3-CH3); HRMS-ES (m/z): Found: 250.1595 (MH+, C18H20N requires:
250.1595).
2,3-Dimethyl-1-((6-methylpyridin-2-yl)methyl)indole 4w
By the same general method, butanone (64 µL, 0.716 mmol, 1.05 eq.), phenylhydrazine
hydrochloride (99 mg, 0.682 mmol, 1 eq.) and 2-(bromomethyl)-6-methylpyridine (133 mg, 0.716
mmol, 1.05 eq.) gave 2,3-dimethyl-1-((6-methylpyridin-2-yl)methyl)indole 4w (120 mg, 70%) as an
amorphous yellow solid, Rf 0.3 (20% ethyl acetate in hexane); νmax = 3054, 2916, 2859, 1593, 1576,
1469, 1459, 1366, 1332, 1183 and 738 cm–1; δH(400 MHz, CDCl3) 7.46–7.41 (1 H, m, 4-H), 7.21 (1 H,
t, J 7.7, pyr 4-H), 7.09–7.04 (1 H, m, 7-H), 7.02–6.97 (2 H, m, 5- and 6-H), 6.87 (1 H, d, J 7.7, pyr 5-H),
6.08 (1 H, d, J 7.7, pyr 3-H), 5.28 (2 H, s, CH2), 2.49 (3 H, s, pyr CH3), 2.21 (3 H, s, 3-CH3) and 2.19 (3 H,
s, 3-CH3); δC(100 MHz, CDCl3) 157.0 (pyr 6), 156.5 (pyr 2), 136.3 (pyr 4), 135.2 (7a), 131.3 (2), 127.7
(3a), 120.7 (pyr 5), 119.8 (6), 118.0 (5), 117.0 (4), 115.8 (pyr 3), 107.7 (7), 106.2 (3), 47.5 (CH2), 23.3
(pyr CH3), 9.0 (2-CH3) and 7.9 (3-CH3); HRMS-ES (m/z): Found: 251.1544 (MH+, C17H19N2 requires:
251.1548).
Conflicts of Interest